pr6b01004_si_005.xlsx (42.83 kB)

Integrated, High-Throughput, Multiomics Platform Enables Data-Driven Construction of Cellular Responses and Reveals Global Drug Mechanisms of Action

Download (42.83 kB)
dataset
posted on 14.01.2017, 00:00 by Jeremy L. Norris, Melissa A. Farrow, Danielle B. Gutierrez, Lauren D. Palmer, Nicole Muszynski, Stacy D. Sherrod, James C. Pino, Jamie L. Allen, Jeffrey M. Spraggins, Alex L. R. Lubbock, Ashley Jordan, William Burns, James C. Poland, Carrie Romer, M. Lisa Manier, Yuan-wei Nei, Boone M. Prentice, Kristie L. Rose, Salisha Hill, Raf Van de Plas, Tina Tsui, Nathaniel M. Braman, M. Ray Keller, Stacey A. Rutherford, Nichole Lobdell, Carlos F. Lopez, D. Borden Lacy, John A. McLean, John P. Wikswo, Eric P. Skaar, Richard M. Caprioli
An understanding of how cells respond to perturbation is essential for biological applications; however, most approaches for profiling cellular response are limited in scope to pre-established targets. Global analysis of molecular mechanism will advance our understanding of the complex networks constituting cellular perturbation and lead to advancements in areas, such as infectious disease pathogenesis, developmental biology, pathophysiology, pharmacology, and toxicology. We have developed a high-throughput multiomics platform for comprehensive, de novo characterization of cellular mechanisms of action. Platform validation using cisplatin as a test compound demonstrates quantification of over 10 000 unique, significant molecular changes in less than 30 days. These data provide excellent coverage of known cisplatin-induced molecular changes and previously unrecognized insights into cisplatin resistance. This proof-of-principle study demonstrates the value of this platform as a resource to understand complex cellular responses in a high-throughput manner.

History